Why the study?
Does the presence of a giant left atrium increase early and late mortality in patients undergoing mitral valve replacement?
Does the presence of a giant left atrium increase early and late mortality in patients undergoing mitral valve replacement?
Answers are grounded in this paper and cite their sources.
Giant left atrium is not a significant risk factor for mortality in mitral valve replacement, suggesting left atrial plication may not be routinely required in the absence of extracardiac compression signs.
Giant left atrium (GLA) associated with mitral valve disease (MVD) has been reported as a significant risk factor in mitral valve surgery with mortality ranging from 8%-32%. Plication of the left atrium has been suggested to reduce postoperative left ventricular failure, respiratory failure and mortality. The 203 consecutive patients with MVD operated upon between 1980 and 1986 were reviewed and divided in two groups: group A without GLA (165 patients) and group B with GLA (38 patients = 19%). The pertinent preoperative and intraoperative notes and the early and late postoperative course were reviewed and correlated. The hospital mortality was 2.4% in group A and 2.6% in group B. Late mortality, at a mean follow-up of 54 months was 4.3% in group A and 5.4% in group B. In this series, GLA was not a significant risk factor in MVR and did not affect early and late results as compared with cases without GLA. Plication may not be required in absence of extracardiac signs of compression.
No takes yet. Share an insight, caveat, or question.
DIEUSANIO et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: